Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Tolerance to self-antigens prevents the elimination of cancer by the immune system . We used synthetic chimeric antigen receptors (CARs) to overcome immunological tolerance and mediate tumor rejection in patients with chronic lymphocytic leukemia (CLL). Remission was induced in a subset of subjects,...

Full description

Saved in:
Bibliographic Details
Published inNature medicine Vol. 24; no. 5; pp. 563 - 571
Main Authors Fraietta, Joseph A, Lacey, Simon F, Orlando, Elena J, Pruteanu-Malinici, Iulian, Gohil, Mercy, Lundh, Stefan, Boesteanu, Alina C, Wang, Yan, O'Connor, Roddy S, Hwang, Wei-Ting, Pequignot, Edward, Ambrose, David E, Zhang, Changfeng, Wilcox, Nicholas, Bedoya, Felipe, Dorfmeier, Corin, Chen, Fang, Tian, Lifeng, Parakandi, Harit, Gupta, Minnal, Young, Regina M, Johnson, F Brad, Kulikovskaya, Irina, Liu, Li, Xu, Jun, Kassim, Sadik H, Davis, Megan M, Levine, Bruce L, Frey, Noelle V, Siegel, Donald L, Huang, Alexander C, Wherry, E John, Bitter, Hans, Brogdon, Jennifer L, Porter, David L, June, Carl H, Melenhorst, J Joseph
Format Journal Article
LanguageEnglish
Published United States Nature Publishing Group 01.05.2018
Subjects
Online AccessGet full text

Cover

Loading…